139 related articles for article (PubMed ID: 1434029)
1. [Analysis of circulating thyroid-stimulating activities in pregnant women with Graves' disease: differential measurement of activities induced by TSH receptor antibody and hCG].
Kaneda T; Tamaki H; Hidaka Y; Amino N; Mitsuda N; Tanizawa O; Miyai K
Rinsho Byori; 1992 Sep; 40(9):941-7. PubMed ID: 1434029
[TBL] [Abstract][Full Text] [Related]
2. Crucial role of serum human chorionic gonadotropin for the aggravation of thyrotoxicosis in early pregnancy in Graves' disease.
Tamaki H; Itoh E; Kaneda T; Asahi K; Mitsuda N; Tanizawa O; Amino N
Thyroid; 1993; 3(3):189-93. PubMed ID: 8257857
[TBL] [Abstract][Full Text] [Related]
3. [Thyroid stimulating antibodies in pregnant women with Graves' disease and neonatal thyrotoxicosis].
Nygaard B; Petersen JR; Jespersen NF
Ugeskr Laeger; 1997 Feb; 159(8):1086-9. PubMed ID: 9072852
[TBL] [Abstract][Full Text] [Related]
4. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
[TBL] [Abstract][Full Text] [Related]
5. Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves' disease and GTT?
Yoshihara A; Noh JY; Mukasa K; Suzuki M; Ohye H; Matsumoto M; Kunii Y; Watanabe N; Suzuki N; Kameda T; Sugino K; Ito K
Endocr J; 2015; 62(6):557-60. PubMed ID: 25819223
[TBL] [Abstract][Full Text] [Related]
6. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
Kung AW; Lau KS; Kohn LD
J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
[TBL] [Abstract][Full Text] [Related]
7. [Laboratory diagnosis before onset and prediction of Graves' disease].
Hidaka Y; Tada H; Amino N
Rinsho Byori; 1997 Sep; 45(9):825-30. PubMed ID: 9311254
[TBL] [Abstract][Full Text] [Related]
8. Physiologic thyroid activation in normal early pregnancy is induced by circulating hCG.
Kimura M; Amino N; Tamaki H; Mitsuda N; Miyai K; Tanizawa O
Obstet Gynecol; 1990 May; 75(5):775-8. PubMed ID: 2158026
[TBL] [Abstract][Full Text] [Related]
9. Universal predictive criteria for neonatal overt thyrotoxicosis requiring treatment.
Tamaki H; Amino N; Aozasa M; Mori M; Iwatani Y; Tachi J; Nose O; Tanizawa O; Miyai K
Am J Perinatol; 1988 Apr; 5(2):152-8. PubMed ID: 2450549
[TBL] [Abstract][Full Text] [Related]
10. Thyroid-stimulating activity in sera of normal pregnant women.
Yoshikawa N; Nishikawa M; Horimoto M; Yoshimura M; Sawaragi S; Horikoshi Y; Sawaragi I; Inada M
J Clin Endocrinol Metab; 1989 Oct; 69(4):891-5. PubMed ID: 2550510
[TBL] [Abstract][Full Text] [Related]
11. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y
Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404
[TBL] [Abstract][Full Text] [Related]
12. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
[TBL] [Abstract][Full Text] [Related]
13. Prediction of post-partum Graves' thyrotoxicosis by measurement of thyroid stimulating antibody in early pregnancy.
Hidaka Y; Tamaki H; Iwatani Y; Tada H; Mitsuda N; Amino N
Clin Endocrinol (Oxf); 1994 Jul; 41(1):15-20. PubMed ID: 7914152
[TBL] [Abstract][Full Text] [Related]
14. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD
J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
[TBL] [Abstract][Full Text] [Related]
15. Therapy insight: management of Graves' disease during pregnancy.
Chan GW; Mandel SJ
Nat Clin Pract Endocrinol Metab; 2007 Jun; 3(6):470-8. PubMed ID: 17515891
[TBL] [Abstract][Full Text] [Related]
16. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.
Schott M; Minich WB; Willenberg HS; Papewalis C; Seissler J; Feldkamp J; Bergmann A; Scherbaum WA; Morgenthaler NG
Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227
[TBL] [Abstract][Full Text] [Related]
17. Partial prediction of postpartum Graves' thyrotoxicosis by sensitive bioassay for thyroid-stimulating antibody measured in early pregnancy.
Ide A; Amino N; Nishihara E; Kudo T; Ito M; Kimura Y; Tatsumi N; Yamazaki M; Miyauchi A
Endocr J; 2016 Oct; 63(10):929-932. PubMed ID: 27432817
[TBL] [Abstract][Full Text] [Related]
18. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
Wallaschofski H; Kuwert T; Lohmann T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for developmental disorders in infants born to women with Graves disease.
Mitsuda N; Tamaki H; Amino N; Hosono T; Miyai K; Tanizawa O
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):359-64. PubMed ID: 1379702
[TBL] [Abstract][Full Text] [Related]
20. Pathogenic role of asialo human chorionic gonadotropin in gestational thyrotoxicosis.
Tsuruta E; Tada H; Tamaki H; Kashiwai T; Asahi K; Takeoka K; Mitsuda N; Amino N
J Clin Endocrinol Metab; 1995 Feb; 80(2):350-5. PubMed ID: 7852489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
